Prana details PBT2 data on reduced Tau Cognitive Impairment
Filed with ASX ·
6ix hasn’t read this filing yet.
Alterity Therapeutics Ltd. on 6ix
Earlier from Alterity Therapeutics
- Prana Updates Progress on PBT2 Trials
- Pranas PBT2 Reverses Memory Loss in Normal Aging
- Prana Provides Update on Clinical Trials for Alzheimers
Later from Alterity Therapeutics
- Appendix 4C - Quarterly report
- Appendix 4E - Preliminary Financial Report
- First Patient Enrolled in Phase II Huntington Disease Trial
- Prana Comments on Neurology Publication Huntington Data
Follow Alterity Therapeutics into a list and get an email when it puts out news.
Follow Alterity Therapeutics